February 17, 2026 / Sciad Communications / Watchmaker Genomics, an innovator in high-performance solutions for next-generation sequencing (NGS), today announced a non-exclusive license with Caribou ...

The Precision Medicine Market represents a transformative shift in global healthcare, focusing on tailoring medical treatment ...

The global whole genome sequencing market size was valued at USD 2.63 billion in 2025 and is predicted to hit around USD 15.96 billion by 2034, rising at a 22.2% CAGR, a study published by Towards ...

Not long after 24-year-old left-hander Jake Miller got settled in the clubhouse, he learned his locker was getting moved. The ...

This news release contains forward-looking information about expected future events that is subject to risks and assumptions set out in the ...

Explore the evolution of T-cell engagers, from experimental concepts to effective therapies for haematologic malignancies.

Pacific Biosciences of California, Inc. ( PACB) Q4 2025 Earnings Call February 12, 2026 5:00 PM EST Good day, and welcome to PacBio's Fourth Quarter and Full Year 2025 Earnings Conference Call. Please ...

Retrotransposons are pivotal in human genome evolution, driving structural variation and regulatory innovation while influencing health and disease.

NSCLC remains the leading cause of cancer-related mortality worldwide, with EGFR mutations being a critical driver in approximately 10-15% of lung adenocarcinomas in Western populations, and up to 40% ...

TORONTO, Feb. 19, 2026 /CNW/ - i-80 GOLD CORP. (TSX: IAU) (NYSE American: IAUX) ("i-80 Gold" or the "Company") reports its ...

Research shows that 77 percent of lab professionals now use public AI tools alongside their ELN. For many, this is not driven by policy decisions, but by necessity. Governed tools do not yet support ...

ProPhase Labs, Inc. (OTC: PRPH) ('ProPhase” or the 'Company”) is pleased to invite investors to a webinar on Tuesday, February 3, 2026, at 4:15 p.m. ET.